Terms: = Skin cancer AND TRRAP, TR-AP, 8295, ENSG00000196367, Q9Y4A5, PAF400, PAF350/400, FLJ10671, STAF40, Tra1 AND Treatment
743 results:
1. Gender Difference in sidE eFfects of ImmuNotherapy: a possible clue to optimize cancer treatment (G-DEFINER): study protocol of an observational prospective multicenter study.
Miceli R; Eriksson H; Lo Russo G; Alfieri S; Moksnes Bjaanæs M; Pietrantonio F; De Cecco L; Prelaj A; Proto C; Franzén J; McDonnell D; Berenguer Pina JJ; Beninato T; Mazzeo L; Giannatempo P; Verzoni E; Crown J; Helland Å; Eustace A
Acta Oncol; 2024 Apr; 63():213-219. PubMed ID: 38647024
[TBL] [Abstract] [Full Text] [Related]
2. How many Italian cancer patients are eligible for, and may respond to, Italian Medicines Agency-approved immune checkpoint inhibitors?
Crocetti E; Ravaioli A; Falcini F; Vattiato R; Mancini S; Baldacchini F; Zamagni F; Vitali B; Balducci C; Bucchi L; Giuliani O
Tumori; 2024 Apr; 110(2):109-115. PubMed ID: 38372036
[TBL] [Abstract] [Full Text] [Related]
3. Water-soluble intracellular extract of Desmodesmus sp. YT enhanced the antioxidant capacity of human skin fibroblast to protect the skin from UV damage.
Ying M; Zeng Z; Li Q; Chen X; Xiong Y; Wu B; Peng L; Zhang Q; Wang L; Dai Z; Li S; Chen H; Yang X
J Cosmet Dermatol; 2024 May; 23(5):1850-1861. PubMed ID: 38327116
[TBL] [Abstract] [Full Text] [Related]
4. COL1A1::PDGFB fusion-associated uterine fibrosarcoma: A case report and review of the literature.
Rota S; Franza A; Fabbroni C; Paolini B; Greco FG; Alessi A; Padovano B; Casali P; Sanfilippo R
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1969. PubMed ID: 38279510
[TBL] [Abstract] [Full Text] [Related]
5. A phase 2, multicenter, open-label study of anti-LAG-3 ieramilimab in combination with anti-PD-1 spartalizumab in patients with advanced solid malignancies.
Lin CC; Garralda E; Schöffski P; Hong DS; Siu LL; Martin M; Maur M; Hui R; Soo RA; Chiu J; Zhang T; Ma B; Kyi C; Tan DS; Cassier PA; Sarantopoulos J; Weickhardt A; Carvajal RD; Spratlin J; Esaki T; Rolland F; Akerley W; Deschler-Baier B; Rispoli L; Samant TS; Chowdhury NR; Gusenleitner D; Kwak EL; Askoxylakis V; De Braud F
Oncoimmunology; 2024; 13(1):2290787. PubMed ID: 38170160
[TBL] [Abstract] [Full Text] [Related]
6. Development of 3D melanoma cultures on a hyaluronic acid-based scaffold with synthetic self-assembling peptides: Electroporation enhancement.
Zamuner A; Dettin M; Dall'Olmo L; Campana LG; Mognaschi ME; Conconi MT; Sieni E
Bioelectrochemistry; 2024 Apr; 156():108624. PubMed ID: 38104458
[TBL] [Abstract] [Full Text] [Related]
7. A Phase 1b/2a Study of GC1118 with 5-Fluorouracil, Leucovorin and Irinotecan (FOLFIRI) in Patients with Recurrent or Metastatic Colorectal cancer.
Lee KW; Han SW; Kim TW; Ahn JB; Baek JY; Cho SH; Lee H; Kim JW; Kim JW; Kim TY; Hong YS; Beom SH; Cha Y; Choi Y; Kim S; Bang YJ
Cancer Res Treat; 2024 Apr; 56(2):590-601. PubMed ID: 38062706
[TBL] [Abstract] [Full Text] [Related]
8. First-in-human study of naporafenib (LXH254) with or without spartalizumab in adult patients with advanced solid tumors harboring MAPK signaling pathway alterations.
Janku F; Kim TM; Iyer G; Spreafico A; Elez E; de Jonge M; Yamamoto N; van der Wekken AJ; Ascierto PA; Maur M; Marmé F; Kiladjian JJ; Basu S; Baffert F; Buigues A; Chen C; Cooke V; Giorgetti E; Kim J; McCarthy F; Moschetta M; Dummer R
Eur J Cancer; 2024 Jan; 196():113458. PubMed ID: 38039779
[TBL] [Abstract] [Full Text] [Related]
9. Taxifolin inhibits melanoma proliferation/migration impeding USP18/Rac1/JNK/β-catenin oncogenic signaling.
Xu L; Zhang L; Zhang S; Yang J; Zhu A; Sun J; Kalvakolanu DV; Cong X; Zhang J; Tang J; Guo B
Phytomedicine; 2024 Jan; 123():155199. PubMed ID: 37995531
[TBL] [Abstract] [Full Text] [Related]
10. Survival of Patients With Head and Neck Merkel Cell cancer: Findings From the Pan-Canadian Merkel Cell cancer Collaborative.
Nayak AL; Pickett AT; Delisle M; Dingley B; Mallick R; Hamilton T; Stuart H; Talbot M; McKinnon G; Jost E; Thiboutot E; Francescutti V; Samman S; Easson A; Schellenberg A; Merchant S; La J; Vanderbeck K; Wright F; Berger-Richardson D; Hebbard P; Hershorn O; Younan R; Patocskai E; Rodriguez-Qizilbash S; Meguerditichian A; Tchuente V; Kazandjian S; Mathieson A; Hossain F; Hetu J; Corsten M; Tohmé A; Nessim C; Johnson-Obaseki S
JAMA Netw Open; 2023 Nov; 6(11):e2344127. PubMed ID: 37983027
[TBL] [Abstract] [Full Text] [Related]
11. MicroRNA-Mediated Antiproliferative Effects of M1 Macrophage-Derived Extracellular Vesicles on Melanoma Cells.
Saleh NA; Rode MP; Cisilotto J; Silva AH; Prigol AN; da Luz Efe F; Winter E; Filippin-Monteiro FB; Creczynski-Pasa TB
Immunol Invest; 2024 Jan; 53(1):70-89. PubMed ID: 37981469
[TBL] [Abstract] [Full Text] [Related]
12. Predictor Variables Associated With Dermatology Referral Completion and the Impact on Surgical treatment: A Retrospective Cohort Study.
Lai J; Bao A; McCaffrey T; Salman R; Gelderen EV; Rizk E; Thompson KG; Epstein JA; Bibee K; Scott J
Dermatol Surg; 2024 Jan; 50(1):28-34. PubMed ID: 37962110
[TBL] [Abstract] [Full Text] [Related]
13. First-in-human phase I/Ib study of NIZ985, a recombinant heterodimer of IL-15 and IL-15Rα, as a single agent and in combination with spartalizumab in patients with advanced and metastatic solid tumors.
Leidner R; Conlon K; McNeel DG; Wang-Gillam A; Gupta S; Wesolowski R; Chaudhari M; Hassounah N; Lee JB; Ho Lee L; O'Keeffe JA; Lewis N; Pavlakis GN; Thompson JA
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37907221
[TBL] [Abstract] [Full Text] [Related]
14. Liver toxicity with ribociclib in a patient with metastatic hormone receptor positive postmenopausal breast cancer.
Sozer Karadagli S; Gursoy P
J Oncol Pharm Pract; 2024 Mar; 30(2):404-407. PubMed ID: 37899576
[TBL] [Abstract] [Full Text] [Related]
15. Plasma Cetuximab Concentrations Correlate With Survival in Patients With Advanced KRAS Wild Type Colorectal cancer.
Jiang DM; Parshad S; Zhan L; Sim HW; Siu LL; Liu G; Shapiro JD; Price TJ; Jonker DJ; Karapetis CS; Strickland AH; Zhang W; Jeffery M; Tu D; Ng S; Sabesan S; Shannon J; Townsend A; O'Callaghan CJ; Chen EX
Clin Colorectal Cancer; 2023 Dec; 22(4):457-463. PubMed ID: 37704538
[TBL] [Abstract] [Full Text] [Related]
16. Effects of treatment methods on cutaneous melanoma related mortality and all-cause mortality in Texas: TCR-Medicare 2007-2017 database.
Ramirez F; Riva H; Digbeu B; Samaniego M; Fernandez L; Mansour S; Vasquez R; Lopez DS; Chacon J
Cancer Causes Control; 2024 Feb; 35(2):265-275. PubMed ID: 37702966
[TBL] [Abstract] [Full Text] [Related]
17. First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: a single-arm, single-centre, phase 2 trial.
Cytryn SL; Moy RH; Cowzer D; Shah RH; Chou JF; Joshi SS; Ku GY; Maron SB; Desai A; Yang J; Sugarman R; Rao D; Goldberg Z; Charalambous C; Lapshina M; Antoine A; Socolow F; Trivedi N; Capanu M; Gerdes H; Schattner MA; Simmons M; Lacouture ME; Paroder V; Tang LH; Shia J; Ilson DH; Solit DB; Berger MF; Janjigian YY
Lancet Oncol; 2023 Oct; 24(10):1073-1082. PubMed ID: 37666264
[TBL] [Abstract] [Full Text] [Related]
18. Effectiveness and toxicity of cetuximab with concurrent RT in locally advanced cutaneous squamous cell skin cancer: a case series.
Chang M; Samlowski W; Meoz R
Oncotarget; 2023 Jul; 14():709-718. PubMed ID: 37417890
[TBL] [Abstract] [Full Text] [Related]
19. Psychological and behavioral symptoms in patients with melanoma: A systematic review and meta-analysis.
Danielsen JT; Strøm L; Knutzen SM; Schmidt H; Amidi A; Wu LM; Zachariae R
Psychooncology; 2023 Aug; 32(8):1208-1222. PubMed ID: 37370196
[TBL] [Abstract] [Full Text] [Related]
20. First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal cancer Group.
Bond MJG; Bolhuis K; Loosveld OJL; de Groot JWB; Droogendijk H; Helgason HH; Hendriks MP; Klaase JM; Kazemier G; Liem MSL; Rijken AM; Verhoef C; de Wilt JHW; de Jong KP; Gerhards MF; van Amerongen MJ; Engelbrecht MRW; van Lienden KP; Molenaar IQ; de Valk B; Haberkorn BCM; Kerver ED; Erdkamp F; van Alphen RJ; Mathijssen-van Stein D; Komurcu A; Lopez-Yurda M; Swijnenburg RJ; Punt CJA;
Lancet Oncol; 2023 Jul; 24(7):757-771. PubMed ID: 37329889
[TBL] [Abstract] [Full Text] [Related]
[Next]
